The ubiquitin-proteasome system in cardiac dysfunction

被引:127
作者
Mearini, Giulia [1 ]
Schlossarek, Saskia [1 ]
Willis, Monte S. [2 ,3 ,4 ]
Carrier, Lucie [1 ,5 ,6 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Inst Expt & Clin Pharmacol & Toxicol, D-20246 Hamburg, Germany
[2] Univ N Carolina, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC USA
[3] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA
[4] Univ N Carolina, Lab Med, Chapel Hill, NC USA
[5] Univ Paris 06, INSERM, U582, F-75013 Paris, France
[6] UPMC Univ Paris 06, UMR S582, IFR14, F-75013 Paris, France
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2008年 / 1782卷 / 12期
关键词
Ubiquitin-proteasome system; Cardiomyopathy; Autophagy; Cardiac disease;
D O I
10.1016/j.bbadis.2008.06.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since proteins play crucial roles in all biological processes, the finely tuned equilibrium between their synthesis and degradation regulates cellular homeostasis. Controlling the quality of proteome informational content is essential for cell survival and function. After initial synthesis, membrane and secretory proteins are modified, folded, and assembled in the endoplasmic: reticulum, whereas other proteins are synthesized and processed in the cytosol. Cells have different protein quality control systems, the molecular chaperones, which help protein folding and stabilization, and the ubiquitin-proteasome system (UPS) and lysosomes, which degrade proteins. It has generally been assumed that UPS and lysosomes are regulated independently and serve distinct functions. The UPS degrades both cytosolic, nuclear proteins, and myofibrillar proteins, whereas the lysosomes degrade most membrane and extracellular proteins by endocyrosis as well as cytosolic proteins and organelles via autophagy. Over the last two decades, the UPS has been increasingly recognized as a major system in several biological processes including cell proliferation, adaptation to stress and cell death. More recently, activation or impairment of the UPS has been reported in cardiac disease and recent evidence indicate that autophagy is a key mechanism to maintain cardiac structure and function. This review mainly focuses on the UPS and its various components in healthy and diseased heart, but also summarizes recent data suggesting parallel activation of the UPS and autophagy in cardiac disease. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:749 / 763
页数:15
相关论文
共 197 条
[11]   Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo [J].
Bodine, SC ;
Stitt, TN ;
Gonzalez, M ;
Kline, WO ;
Stover, GL ;
Bauerlein, R ;
Zlotchenko, E ;
Scrimgeour, A ;
Lawrence, JC ;
Glass, DJ ;
Yancopoulos, GD .
NATURE CELL BIOLOGY, 2001, 3 (11) :1014-1019
[12]   Identification of ubiquitin ligases required for skeletal muscle atrophy [J].
Bodine, SC ;
Latres, E ;
Baumhueter, S ;
Lai, VKM ;
Nunez, L ;
Clarke, BA ;
Poueymirou, WT ;
Panaro, FJ ;
Na, EQ ;
Dharmarajan, K ;
Pan, ZQ ;
Valenzuela, DM ;
DeChiara, TM ;
Stitt, TN ;
Yancopoulos, GD ;
Glass, DJ .
SCIENCE, 2001, 294 (5547) :1704-1708
[13]   REGULATION OF MYOSIN HEAVY-CHAIN AND ACTIN ISOGENES EXPRESSION DURING CARDIAC GROWTH [J].
BOHELER, KR ;
CARRIER, L ;
CHASSAGNE, C ;
DELABASTIE, D ;
MERCADIER, JJ ;
SCHWARTZ, K .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1991, 104 (1-2) :101-107
[14]   The base of the proteasome regulatory particle exhibits chaperone-like activity [J].
Braun, BC ;
Glickman, M ;
Kraft, R ;
Dahlmann, B ;
Kloetzel, PM ;
Finley, D ;
Schmidt, M .
NATURE CELL BIOLOGY, 1999, 1 (04) :221-226
[15]   Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion [J].
Bulteau, AL ;
Lundberg, KC ;
Humphries, KM ;
Sadek, HA ;
Szweda, PA ;
Friguet, B ;
Szweda, LI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (32) :30057-30063
[16]   The SCF ubiquitin ligase: Insights into a molecular machine [J].
Cardozo, T ;
Pagano, M .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (09) :739-751
[17]   Cardiac myosin-binding protein C and hypertrophic cardiomyopathy [J].
Carrier, L ;
Bonne, G ;
Schwartz, K .
TRENDS IN CARDIOVASCULAR MEDICINE, 1998, 8 (04) :151-157
[18]   Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice [J].
Carrier, L ;
Knöll, R ;
Vignier, N ;
Keller, DI ;
Bausero, P ;
Prudhon, B ;
Isnard, R ;
Ambroisine, ML ;
Fiszman, M ;
Ross, J ;
Schwartz, K ;
Chien, KR .
CARDIOVASCULAR RESEARCH, 2004, 63 (02) :293-304
[19]   Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy [J].
Carrier, L ;
Bonne, G ;
Bahrend, E ;
Yu, B ;
Richard, P ;
Niel, F ;
Hainque, B ;
Cruaud, C ;
Gary, F ;
Labeit, S ;
Bouhour, JB ;
Dubourg, O ;
Desnos, M ;
Hagege, AA ;
Trent, RJ ;
Komajda, M ;
Fiszman, M ;
Schwartz, K .
CIRCULATION RESEARCH, 1997, 80 (03) :427-434
[20]  
Carrier L, 2007, ARCH MAL COEUR VAISS, V100, P238